New antipsychotic drugs: how do their receptor-binding profiles compare?

J Clin Psychiatry. 2010 Sep;71(9):1243-4. doi: 10.4088/JCP.10ac06470yel.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antipsychotic Agents / pharmacokinetics
  • Antipsychotic Agents / pharmacology*
  • Antipsychotic Agents / toxicity
  • Brain / drug effects
  • Brain / metabolism
  • Clozapine / pharmacokinetics
  • Clozapine / pharmacology
  • Clozapine / toxicity
  • Dibenzocycloheptenes
  • Heterocyclic Compounds, 4 or More Rings / pharmacokinetics
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Heterocyclic Compounds, 4 or More Rings / toxicity
  • Humans
  • Isoxazoles / pharmacokinetics
  • Isoxazoles / pharmacology*
  • Isoxazoles / toxicity
  • Paliperidone Palmitate
  • Piperidines / pharmacokinetics
  • Piperidines / pharmacology*
  • Piperidines / toxicity
  • Pyrimidines / pharmacokinetics
  • Pyrimidines / pharmacology*
  • Pyrimidines / toxicity
  • Receptors, Neurotransmitter / antagonists & inhibitors*
  • Receptors, Neurotransmitter / metabolism

Substances

  • Antipsychotic Agents
  • Dibenzocycloheptenes
  • Heterocyclic Compounds, 4 or More Rings
  • Isoxazoles
  • Piperidines
  • Pyrimidines
  • Receptors, Neurotransmitter
  • Clozapine
  • asenapine
  • Paliperidone Palmitate
  • iloperidone